20150527-IR-856150150ERA Temporarily amends 856 IAC 2-2-2 to add synthetic drug compounds to Schedule I. Statutory authority: IC 25-26-13-4.1. Effective 30 days after filing with the Publisher.

TITLE 856 INDIANA BOARD OF PHARMACY

Emergency Rule LSA Document #15-150(E)

DIGEST

Temporarily amends 856 IAC 2-2-2 to add synthetic drug compounds to Schedule I. Statutory authority: IC 25-26-13-4.1. Effective 30 days after filing with the Publisher.

SECTION 1. (a) This SECTION is supplemental to 856 IAC 2-2-2.

(b) Unless specifically excepted or unless listed in another schedule, any material compound, mixture, or preparation, which contains any quantity of the following synthetic drugs, or which contains any of its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this subsection only, "isomer" includes the optical, position and geometric isomers):

(1) PB-22 (Other names include: 1-Pentyl-8-quinolinyl ester-1H-indole-2-carboxylic acid).

(2) 5-Fluoro-PB-22 (Other names include: 1-(5-Fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid).

(3) Benocyclidine (Other names include: BCP, BTCP, and Benzothiophenylcyclohexylpiperidine).

(4) 25B-NBOMe (Other names include: 2C-B-NBOMe and 4-Bromo-2, 5-dimethoxy-N-[(2-Methoxyphenyl)methyl]benzeneethanamine).

(5) APB (Other names include: (2-Aminopropyl)Benzofuran).

(6) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide).

(7) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide).

(8) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide).

(9) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(fluoropentyl)-1H-indole-3-carboxamide).

(10) APDB (Other names include: -EMA, -Desoxy-MDA, and (2-Aminopropyl)-2,3-dihydrobenzofuran.)

(11) THJ-2201 (Other names include: AM2201 indazole analog, Fluoropentyl-JWH-018 indazole, and 5-Fluoro-THJ-018).

(12) AM2201 benzimidazole analog (Other names include: FUBIMINA, FTHJ, and (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-yl)(naphthalen-1-yl)methanone).

(13) MN-25 (Other names include: 7-methoxy-1-[2-(4-morpholinyl)ethyl]-N-[(1S, 2S, 4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide and UR-12).

(14) FUB-PB-22 (Other names include: Quinolin-8-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).

(15) FDU-PB-22 (Other names include: Naphthalen-1-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).

(16) 5-Fluoro-AB-PINACA (Other names include: AB-PINACA 5-fluoro analog and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide).

(17) 4-MePPP (Other names include: 4-methyl-alpha-pyrrolidinopropiophenone).

(18) alpha-PBP (Other names include: Alpha-pyrrolidinobutiophenone).

(19) AB-CHMINACA (Other names include: (N-[1-(aminocarbonyl)-2-methylpropyl]-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide).

LSA Document #15-150(E)

Filed with Publisher: May 19, 2015, 1:26 p.m.

Posted: 05/27/2015 by Legislative Services Agency

DIN: 20150527-IR-856150150ERA

Composed: Nov 01,2016 2:01:33AM EDT

A PDF version of this document.